| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 120 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 120 |
| 2 | TACROLIMUS | 107 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 98 |
| 4 | TACROLIMUS OINTMENT 0.1% | 98 |
| 5 | PREDNISONE | 76 |
| 6 | VALGANCICLOVIR | 76 |
| 7 | VALGANCICLOVIR HYDROCHLORIDE | 76 |
| 8 | PREDNISOLONE | 74 |
| 9 | PREDNISOLONE ORAL | 74 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUPREDNATE OPHTHALMIC | 6 | 0.0068 |
| 1 | IMIPRAMINE HYDROCHLORIDE | 3 | 0.0053 |
| 2 | FLURAZEPAM HYDROCHLORIDE | 2 | 0.0049 |
| 3 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 5 | 0.0048 |
| 4 | VALGANCICLOVIR | 76 | 0.0040 |
| 5 | GANCICLOVIR SODIUM | 40 | 0.0037 |
| 6 | OLOPATADINE HCL | 1 | 0.0027 |
| 7 | FOSCARNET SODIUM | 11 | 0.0027 |
| 8 | AMPICILLIN AND SULBACTAM | 2 | 0.0023 |
| 9 | MOGAMULIZUMAB-KPKC | 2 | 0.0015 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 85 | 0.0038 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 2 | 0.0015 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 25 | 0.0012 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 15 | 0.0008 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 5 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Nucleoside Analog Antiviral [EPC] | 41 | 0.0005 |
| 8 | Human Immunoglobulin G [EPC] | 8 | 0.0004 |
| 9 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |